Insight Molecular Diagnostics (IMDX) Shares Issued (2020 - 2025)
Historic Shares Issued for Insight Molecular Diagnostics (IMDX) over the last 5 years, with Q1 2025 value amounting to $29.1 million.
- Insight Molecular Diagnostics' Shares Issued changed N/A to $29.1 million in Q1 2025 from the same period last year, while for Sep 2025 it was $39.3 million, marking a year-over-year increase of 14892.77%. This contributed to the annual value of $26.0 million for FY2024, which is 8783.94% up from last year.
- Per Insight Molecular Diagnostics' latest filing, its Shares Issued stood at $29.1 million for Q1 2025.
- Insight Molecular Diagnostics' 5-year Shares Issued high stood at $65.3 million for Q1 2021, and its period low was $1000.0 during Q4 2021.
- In the last 4 years, Insight Molecular Diagnostics' Shares Issued had a median value of $10.2 million in 2024 and averaged $17.9 million.
- Per our database at Business Quant, Insight Molecular Diagnostics' Shares Issued surged by 75904.96% in 2021 and then tumbled by 9995.25% in 2022.
- Quarter analysis of 4 years shows Insight Molecular Diagnostics' Shares Issued stood at $1000.0 in 2021, then skyrocketed by 499900.0% to $5.0 million in 2022, then skyrocketed by 104.1% to $10.2 million in 2024, then surged by 185.58% to $29.1 million in 2025.
- Its Shares Issued stands at $29.1 million for Q1 2025, versus $10.2 million for Q4 2024 and $15.8 million for Q2 2024.